Cargando…
A novel minigene scaffold for therapeutic cancer vaccines
Genetic vaccines are emerging as a powerful modality to induce T-cell responses to target tumor associated antigens (TAA). Viral or plasmid DNA or RNA vectors harbor an expression cassette encoding the antigen of choice delivered in vivo by vaccination. In this context, immunizations with minigenes...
Autores principales: | Aurisicchio, Luigi, Fridman, Arthur, Bagchi, Ansuman, Scarselli, Elisa, La Monica, Nicola, Ciliberto, Gennaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002591/ https://www.ncbi.nlm.nih.gov/pubmed/24790791 http://dx.doi.org/10.4161/onci.27529 |
Ejemplares similares
-
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
por: Aurisicchio, Luigi, et al.
Publicado: (2020) -
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
por: Diaz, Claudia Marcela, et al.
Publicado: (2013) -
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform
por: Fridman, Arthur, et al.
Publicado: (2012) -
Emerging Cancer Vaccines: The Promise of Genetic Vectors
por: Aurisicchio, Luigi, et al.
Publicado: (2011) -
The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018)